Cargando…
Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems
PURPOSE: Our purpose was to compare the procedural characteristics, success rate, and complication rate of the conventional fluoroscopic (CF) and the zero-fluoroscopic (ZF) approach in patients undergoing catheter ablation of AVNRT or typical atrial flutter (Aflu). METHODS: 186 consecutive patients...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407085/ https://www.ncbi.nlm.nih.gov/pubmed/37560116 http://dx.doi.org/10.3389/fcvm.2023.1185187 |
_version_ | 1785085875899596800 |
---|---|
author | Piros, Katalin Perge, Péter Salló, Zoltán Herczeg, Szilvia Nagy, Vivien Klaudia Osztheimer, István Merkely, Béla Gellér, László Szegedi, Nándor |
author_facet | Piros, Katalin Perge, Péter Salló, Zoltán Herczeg, Szilvia Nagy, Vivien Klaudia Osztheimer, István Merkely, Béla Gellér, László Szegedi, Nándor |
author_sort | Piros, Katalin |
collection | PubMed |
description | PURPOSE: Our purpose was to compare the procedural characteristics, success rate, and complication rate of the conventional fluoroscopic (CF) and the zero-fluoroscopic (ZF) approach in patients undergoing catheter ablation of AVNRT or typical atrial flutter (Aflu). METHODS: 186 consecutive patients with an indication for AVNRT or Aflu ablation were enrolled. Based on the operator's preference, the patients were assigned to either CF or ZF group. In the ZF group EnSite NavX, Carto3, or Rhythmia EAMS were used for catheter guidance. RESULTS: The median age was 56 (IQR = 42−68) years, 144 patients had AVNRT, and 42 had Aflu ablation. CF approach was chosen in 123 cases, while ZF in 63 cases. ZF approach was used more often in case of AVNRT patients [56 (39%) vs. 7 (17%), p = 0.006] and in the case of female patients [43 (68%) vs. 20 (32%), p = 0.008]. Acute procedural success was obtained in all cases. There was no difference in the complication rate (1 vs. 1, p > 0.99) between the two groups. No difference was found regarding the procedure time between the CF and ZF groups [CF: 55 (46–60) min, ZF 60 (47–65) min; p = 0.487] or in the procedure time for the different EAMS [EnSite NavX: 58 (50–63) min, Carto3: 60 (44.5–66.3) min, Rhythmia: 55 (35–69) min; p = 0.887]. A similar success rate was seen at the 3-month follow-up in the two groups [41 (100%) vs. 96 (97%); p = 0.55]. DISCUSSION: The ZF approach demonstrated non-inferiority in safety and efficacy compared with CF for the AVNRT and Aflu ablations. |
format | Online Article Text |
id | pubmed-10407085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104070852023-08-09 Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems Piros, Katalin Perge, Péter Salló, Zoltán Herczeg, Szilvia Nagy, Vivien Klaudia Osztheimer, István Merkely, Béla Gellér, László Szegedi, Nándor Front Cardiovasc Med Cardiovascular Medicine PURPOSE: Our purpose was to compare the procedural characteristics, success rate, and complication rate of the conventional fluoroscopic (CF) and the zero-fluoroscopic (ZF) approach in patients undergoing catheter ablation of AVNRT or typical atrial flutter (Aflu). METHODS: 186 consecutive patients with an indication for AVNRT or Aflu ablation were enrolled. Based on the operator's preference, the patients were assigned to either CF or ZF group. In the ZF group EnSite NavX, Carto3, or Rhythmia EAMS were used for catheter guidance. RESULTS: The median age was 56 (IQR = 42−68) years, 144 patients had AVNRT, and 42 had Aflu ablation. CF approach was chosen in 123 cases, while ZF in 63 cases. ZF approach was used more often in case of AVNRT patients [56 (39%) vs. 7 (17%), p = 0.006] and in the case of female patients [43 (68%) vs. 20 (32%), p = 0.008]. Acute procedural success was obtained in all cases. There was no difference in the complication rate (1 vs. 1, p > 0.99) between the two groups. No difference was found regarding the procedure time between the CF and ZF groups [CF: 55 (46–60) min, ZF 60 (47–65) min; p = 0.487] or in the procedure time for the different EAMS [EnSite NavX: 58 (50–63) min, Carto3: 60 (44.5–66.3) min, Rhythmia: 55 (35–69) min; p = 0.887]. A similar success rate was seen at the 3-month follow-up in the two groups [41 (100%) vs. 96 (97%); p = 0.55]. DISCUSSION: The ZF approach demonstrated non-inferiority in safety and efficacy compared with CF for the AVNRT and Aflu ablations. Frontiers Media S.A. 2023-07-25 /pmc/articles/PMC10407085/ /pubmed/37560116 http://dx.doi.org/10.3389/fcvm.2023.1185187 Text en © 2023 Piros, Perge, Salló, Herczeg, Nagy, Osztheimer, Merkely, Gellér and Szegedi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Piros, Katalin Perge, Péter Salló, Zoltán Herczeg, Szilvia Nagy, Vivien Klaudia Osztheimer, István Merkely, Béla Gellér, László Szegedi, Nándor Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems |
title | Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems |
title_full | Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems |
title_fullStr | Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems |
title_full_unstemmed | Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems |
title_short | Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems |
title_sort | zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with ensite navx, carto3, and rhythmia mapping systems |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407085/ https://www.ncbi.nlm.nih.gov/pubmed/37560116 http://dx.doi.org/10.3389/fcvm.2023.1185187 |
work_keys_str_mv | AT piroskatalin zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems AT pergepeter zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems AT sallozoltan zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems AT herczegszilvia zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems AT nagyvivienklaudia zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems AT osztheimeristvan zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems AT merkelybela zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems AT gellerlaszlo zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems AT szegedinandor zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems |